Janssen Pharmaceutical Inc.
NEWS
Check out some news happening today around the biopharma industry.
The therapy is a one-time, outpatient, intravitreal (into the eye) injection to preserve eyesight in patients with geographic atrophy.
It was relatively quiet in terms of COVID-19-related clinical trials, but there was still quite a bit of news for trials involving other indications. Here’s a look.
There was a handful of positive clinical trial news reported today. Here’s a look.
Grand River Aseptic Manufacturing (GRAM) inked a deal with Janssen Pharmaceutical, a Johnson & Johnson company, to support the manufacturing of Janssen’s COVID-19 vaccine candidate.
The European Society of Medical Oncology (ESMO) Virtual Congress 2020 was last weekend and the beginning of the week, which resulted in numerous clinical trial announcements. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.
The European Society for Medical Oncology (ESMO) Virtual Congress 2020 was this weekend, with numerous companies presenting clinical trial data and updates.
It was a fairly busy week for clinical trial announcements, with some important and interesting news about COVID-19 treatments and vaccines, as well as numerous stories about non-COVID-19 studies.
JOBS
IN THE PRESS